New Topical PDE4 Inhibitor Gets FDA Green Light for Chronic Skin Disease
(MedPage Today) -- The FDA has approved the topical phosphodiesterase 4 (PDE4) inhibitor difamilast (Adquey) as a new option for ...
(MedPage Today) -- The FDA has approved the topical phosphodiesterase 4 (PDE4) inhibitor difamilast (Adquey) as a new option for ...
(MedPage Today) -- LAS VEGAS -- Prior exposure to anti-tumor necrosis factor (TNF) therapy was associated with a lower risk ...
(MedPage Today) -- First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.